C2I2.org
 Index to all volumes
  2008
  2007
  2006
  2005
  2004
  2003
 Useful web site addresses
 Contacting C2I2

Search for:
Type a word or a phrase. All forms of the word are searchable.

Click here to register to get free access to the newest editions on-line

Supported by


Katerina Malagari is Associate Professor of Radiology at the University of Athens, Greece. She is part of a research team for the National Referral Center for Liver Diseases and Hepatocellular Carcinoma and a co-investigator in the Precision V multicentre study, a randomised trial comparing doxorubicin-eluting beads with conventional chemoembolization in the treatment of HCC. She has contributed several scientific papers and abstracts to international peer-reviewed journals.
Drug-eluting beads: a new opportunity in the treatment of hepatocellular carcinoma

Katerina Malagari
Associate Professor of Radiology, University of Athens, Greece

Address for correspondence:
Dr Katerina Malagari, MD
2nd Department of Radiology
University of Athens, 19 Monis Kyccou
15669 Papagou, Athens, Greece
Tel/Fax: +30-210-651–0340
Email: kmalag@acn.gr

Abstract
Drug-eluting beads represent a new technology in selective locoregional treatment. Doxorubicin-eluting beads have been tested in vitro and in vivo and the first results of clinical series are being released. The safety and efficacy of doxorubicin-loaded beads in the treatment of hepatocellular carcinoma are discussed in detail in this review.